Ghrelin has been found to have a positive hepatoprotective effect in fatty liver disease and inflammatory liver disease, and may become a new drug target involved in the evaluation of liver reserve function and liver disease treatment in the future (Mao et al., 2015a; Ezquerro et al., 2020). The gene discussed is GHRL; the disease is fatty liver disease.